KM
Kevin McCulloch (See Remarks) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $723K of XERS (90,000 sh × $8.03, as filed), executed Jul 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Nov 5
Filed Nov 6
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $110K
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 1 buy · 8 sells
9 filings
Recent filings
XERSPURCHASE
Xeris Biopharma Holdings, Inc.
View filing →
$110K25,000 sh × $4.38
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET